DK76688A - VACCINE CONTAINING F-PROTEIN FROM AIDS VIRUS - Google Patents

VACCINE CONTAINING F-PROTEIN FROM AIDS VIRUS

Info

Publication number
DK76688A
DK76688A DK076688A DK76688A DK76688A DK 76688 A DK76688 A DK 76688A DK 076688 A DK076688 A DK 076688A DK 76688 A DK76688 A DK 76688A DK 76688 A DK76688 A DK 76688A
Authority
DK
Denmark
Prior art keywords
protein
vaccine containing
aids virus
aids
virus
Prior art date
Application number
DK076688A
Other languages
Danish (da)
Other versions
DK76688D0 (en
Inventor
Marie-Paule Kieny
Guy Bruno
Jean-Pierre Lecocq
Luc Montagnier
Original Assignee
Transgene Sa
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa, Pasteur Institut filed Critical Transgene Sa
Publication of DK76688D0 publication Critical patent/DK76688D0/en
Publication of DK76688A publication Critical patent/DK76688A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Viral vector characterized in that it comprises at least one portion of the genome of a virus, a gene coding for the protein F of the virus responsible for AIDS, as well as the elements providing for the expression of said protein in cells. Said viral vector may be used as vaccine in the treatment, prevention and diagnosis of AIDS.
DK076688A 1986-06-16 1988-02-15 VACCINE CONTAINING F-PROTEIN FROM AIDS VIRUS DK76688A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608698A FR2600079B1 (en) 1986-06-16 1986-06-16 VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN F OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A, CELL CULTURE INFECTED WITH THIS VECTOR, PROCESS FOR PREPARING THE PROTEIN, OBTAINED PROTEIN, VACCINE AND ANTIBODIES OBTAINED
PCT/FR1987/000219 WO1987007642A1 (en) 1986-06-16 1987-06-15 Vaccine containing the protein f of the aids virus

Publications (2)

Publication Number Publication Date
DK76688D0 DK76688D0 (en) 1988-02-15
DK76688A true DK76688A (en) 1988-02-15

Family

ID=9336386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK076688A DK76688A (en) 1986-06-16 1988-02-15 VACCINE CONTAINING F-PROTEIN FROM AIDS VIRUS

Country Status (11)

Country Link
EP (1) EP0253693B1 (en)
JP (1) JPH01500962A (en)
KR (1) KR880701285A (en)
AT (1) ATE103980T1 (en)
AU (1) AU614934B2 (en)
DE (1) DE3789525T2 (en)
DK (1) DK76688A (en)
ES (1) ES2062990T3 (en)
FR (1) FR2600079B1 (en)
PT (1) PT85093B (en)
WO (1) WO1987007642A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615623B1 (en) * 1987-05-22 1992-06-19 Transgene Sa AIDS DIAGNOSIS TEST BASED ON THE EVIDENCE OF A DIVERSITY OF ISOTYPIC RESPONSE, VACCINES AND SEROTHERAPIES
FR2620030B1 (en) * 1987-09-07 1990-03-23 Transgene Sa VECTOR FOR THE EXPRESSION OF PROTEINS OF HIV-2 VIRUS, A CAUSAL AGENT FOR AIDS, CELL CULTURE INFECTED OR TRANSFORMED THROUGH THIS VECTOR, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
EP0349354A1 (en) * 1988-04-01 1990-01-03 Institut Pasteur Peptides PF10 to PF19 from a retro virus HIV, method for the synthesis of these peptides and their use, particularly in diagnostics
FR2629459B1 (en) * 1988-04-01 1990-12-21 Pasteur Institut PEPTIDES PF11 TO PF19 OF AN HIV RETROVIRUS - PROCESS FOR THE SYNTHESIS OF THESE PEPTIDES - THEIR USE IN PARTICULAR FOR DIAGNOSIS
FR2629460B1 (en) * 1988-04-01 1990-12-21 Pasteur Institut PF16 PEPTIDES OF A HIV RETROVIRUS - PROCESS FOR THE SYNTHESIS OF THESE PEPTIDES - THEIR USE FOR DIAGNOSIS
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
WO1991018990A1 (en) * 1990-05-28 1991-12-12 The Research Foundation For Microbial Diseases Of Osaka University Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
FR2766091A1 (en) 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION

Also Published As

Publication number Publication date
DK76688D0 (en) 1988-02-15
PT85093A (en) 1987-07-01
DE3789525T2 (en) 1994-08-25
ES2062990T3 (en) 1995-01-01
ATE103980T1 (en) 1994-04-15
EP0253693A1 (en) 1988-01-20
WO1987007642A1 (en) 1987-12-17
KR880701285A (en) 1988-07-26
PT85093B (en) 1990-03-30
JPH01500962A (en) 1989-04-06
DE3789525D1 (en) 1994-05-11
FR2600079A1 (en) 1987-12-18
AU7514087A (en) 1988-01-11
AU614934B2 (en) 1991-09-19
EP0253693B1 (en) 1994-04-06
FR2600079B1 (en) 1989-10-20

Similar Documents

Publication Publication Date Title
ES2194029T3 (en) VIRUS VARIATIONS HIV-2.
GR3034708T3 (en) Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.
EP0256092A4 (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same.
DE3789973D1 (en) Dental implant for the attachment of denture superstructures.
CA2186044A1 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
DK641787A (en) VIRUS VECTOR CODING A GLYCOPROTEIN FROM THE VIRUS RESPONSIBLE FOR AIDS, VACCINE COVERING THE VIRUS VECTOR OR GLYCOPROTEIN, AND ANTIBODY AGAINST THE GLYCOPROTEIN
DK76688A (en) VACCINE CONTAINING F-PROTEIN FROM AIDS VIRUS
ATE310828T1 (en) IMPLANT AND VECTOR FOR THE TREATMENT OF ACQUIRED DISEASES
DK498387D0 (en) Viral DNA SEQUENCE
DE58909339D1 (en) Human papilloma virus type 57, its DNA and the proteins encoded by it.
DK631387A (en) viral vector
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
ATE132527T1 (en) NON-REMUTATING RNA VIRUSES
ATE84070T1 (en) VARIANTS OF LAV VIRUSES, THEIR DNA AND PROTEIN COMPONENTS AND THEIR USE, PARTICULARLY FOR DIAGNOSTIC PURPOSES AND FOR THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS.
RU92016478A (en) METHOD OF DIAGNOSTIC HEPATITIS, METHOD OF TREATING HEPATITIS
NL300254I1 (en) Attenuated herpes viruses, herpes viruses comprising foreign DNA encoding an amino acid sequence and vaccine containing it.
ATE98379T1 (en) HUMAN B-LYMPHOTROPIC VIRUS (HBLV) TESTING PROCEDURE.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment